allylamine has been researched along with Dyslipidemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bangit, JR; Batsell, RR; Miraskar, RA; Reddy, KJ; Singh, M; Zaheer, MS | 1 |
Levy, P | 1 |
Insull, W | 1 |
Armani, A; Toth, PP | 1 |
Davidson, MH | 1 |
4 review(s) available for allylamine and Dyslipidemia
Article | Year |
---|---|
Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
Topics: Adult; Allylamine; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Dyslipidemias; Humans | 2010 |
Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.
Topics: Allylamine; Bile Acids and Salts; Cholesterol; Colesevelam Hydrochloride; Colestipol; Dyslipidemias; Humans; Hypolipidemic Agents; Lipids; Treatment Outcome | 2006 |
Colesevelam hydrochloride in the management of dyslipidemia.
Topics: Allylamine; Anion Exchange Resins; Anticholesteremic Agents; Azetidines; Colesevelam Hydrochloride; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Patient Compliance | 2006 |
The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.
Topics: Allylamine; Animals; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2007 |
1 other study(ies) available for allylamine and Dyslipidemia
Article | Year |
---|---|
Lipoprotein-associated phospholipase A2 mass is significantly reduced in dyslipidemic patients treated with lifestyle modification and combination lipid-modifying drug therapy.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Allylamine; Anticholesteremic Agents; Azetidines; Biomarkers; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acids, Omega-3; Female; Humans; Inflammation; Life Style; Male; Middle Aged; Niacin; Regression Analysis; Retrospective Studies; Risk Factors; Simvastatin; Statistics as Topic; Vitamin B Complex | 2010 |